An Exploratory Study of Obinutuzumab β in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (ChiCTR) - Oct 16, 2026 - P=N/A | N=24 | Not yet recruiting | Sponsor: The Second Affiliated Hospital of the Army Medical University; The Second Affiliated Hospital of the Army Medical University
New trial
|